Jump directly to content

Industrial biotechnology – from strain development to scale-up

Biotechnology offering

Biotechnology offers solutions to some of the greatest challenges of our time - from curing diseases and securing food supply to fighting climate change and preserving our environment. RISE offers cutting-edge expertise in industrial biotechnology to accelerate innovation and commercialisation of new solutions.

Our offer covers the entire value chain - from design of advanced microorganisms to development and scale-up of robust bioprocesses in food-grade environments - to transform renewable raw materials into high-value products in an efficient and sustainable way.

Strain development

Using the latest technologies in synthetic biology, high throughput screening and adaptive laboratory evolution, we design and optimise microorganisms tailored to your specific production needs. Our strain development offering includes:

  • Rapid selection and engineering of conventional and unconventional microorganisms
  • Improved metabolic capacity, product yield and stress tolerance
  • Customised product profiles for increased purity, stability and functionality
  • Shorter development time and lower costs through automated cultivation and modular genetic tools

With our methodology, technical and regulatory barriers can be overcome and new opportunities opened up for bio-based chemicals, enzymes, food ingredients and more.

Process development and scale-up

We offer process development from lab-scale optimisation to pilot production with a focus on efficient scale-up. Our services include:

  • Feedstock screening and strategic road-mapping to select optimal raw materials based on composition, availability, cost and sustainability
  • Pretreatment (mechanical, chemical, biological, thermal) to maximise biomass conversion
  • Industrial fermentation expertise from micro-scale bioreactors to food-grade pilot plants with reactors up to 10 m³
  • Advanced downstream processing such as centrifugation, ultrafiltration, homogenisation and drying to optimise product recovery and purification
  • Data-driven process control and validation to ensure reproducibility, robustness and cost efficiency
  • Technoeconomic and sustainability assessments are available as part of our process development to support cost-efficient, scalable, and environmentally sound solutions.

By working closely with RISE’s multidisciplinary team, we mitigate scale-up risks, optimise yields and reduce time to market for sustainable food ingredients, feed, biofuels, biochemicals and more.

Contact us for further dialogue

By combining cutting-edge strain engineering with comprehensive process development and scale-up, RISE supports your journey from concept to commercial success. Contact us to discuss how our expert team can help transform your idea into a sustainable, market-ready product – with your business goals at the centre.

Björn Alriksson

Affärsutvecklare
+46 10 516 67 53 Read more about Björn
Profile image

Contact Björn

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

Gunnar Westin

Gruppchef
+46 10 516 67 57 Read more about Gunnar
Profile image

Contact Gunnar

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Hide menu: Off
bg_5
Division: Division Bioeconomy Område: Biorefinery Biotechnology Sekundär områdes navigation:
Power production
Production and manufacturing
Biobased circular processes
Food
Biobased materials

Fermentation gets the job done - here's the process that enables the protein shift

fermentation fungus

Fermentation is more than just trendy kombucha and kimchi – the ancient preservation method is being used to develop alternative protein sources. But how does it work? And what are the challenges?

The food system accounts for between 20-30% of total global greenhouse gas emissions. At the same time, the world's population is growing and so is the need for food. A protein shift, replacing animal proteins with plant proteins, has been identified as a possible solution to both challenges.

Fermentation is a natural process

Researchers are tackling the issue of protein metabolism in a variety of ways, including at RISE using a thousand-year-old technique that has historically been used to extend the shelf life of food and drink. Fermentation is a natural process in which microorganisms such as bacteria, yeast and moulds convert one substance into another. When 'fed' with sugar or other carbon sources, microorganisms can produce substances such as acid and alcohol (which affect flavour and preservability), or grow into a protein-rich biomass that can form the basis of novel foods.

"There are really three distinct strands to our work on fermentation and novel foods. The first is to process side streams from the industry. One example is rapeseed press cake, which is what remains after pressing rapeseed oil. It is high in protein and fibre, but has a bitter taste. Here, fermentation could be used to improve the flavour, by adding microorganisms that taste good themselves or that break down the bitter substances," explains Jenny Veide Vilg, Head of Microbiology and Hygiene at RISE.

"This is just one example of how it is possible to reduce waste and increase resource efficiency while creating new foods.

"Another track is called single cell protein. Here, it is the actual cells and proteins in a fungus or yeast that are targeted. By feeding the fungus or yeast with sugar and nutrients, they can grow rapidly and create a huge amount of biomass, which could, for example, replace soya in feed or food. "It's like growing protein in tanks instead of fields," says Jenny Veide Vilg.

We can actually do everything in fermentation, from the selection of suitable microorganisms to biotechnological and genetic adaptation to the finished product.

Living factories produce milk protein without cows

The third route is precision fermentation, in which microorganisms are genetically reprogrammed to produce specific substances or ingredients. For example, it is possible to program yeasts to produce the milk protein casein, which can be used to make vegan cheese and ice cream. In principle, microorganisms can be modified to produce exactly the protein you want.

"When we make these kinds of genetic changes, we have to find a way to keep them in the organisms. In the lab, we give organisms an evolutionary advantage if they carry a particular gene, so they keep it. Outside the lab, it's harder to have this control, so it's important to make the process robust and scalable," says Jenny Veide Vilg.

From the lab to the lunchbox

Fermentation is researched and tested on several fronts at RISE, not least at the food-approved facilities in Gothenburg and Örnsköldsvik. Food manufacturers come here with their challenges, ranging from flavours in new products to unused by-products, to take advantage of the technical infrastructure and knowledge.

"In fact, we can do everything in fermentation, from selecting the right micro-organism, through biotechnological and genetic adaptation, to the finished product. Thanks to the newly built facility in Örnsköldsvik, we can now also research and develop processes on a scale of up to 10,000 litres, which is important for creating the conditions for scalability," says Jenny Veide Vilg.

"Scaling up is one thing," she stresses, "but moving from research to a product that people want to eat is perhaps the biggest challenge.

"We have researchers at RISE working on the taste and texture of food, but also on neophobia, the phobia of trying new things. In the marine sector, a lot of work is being done to encourage consumers to eat seafood other than cod, salmon and herring. This work must also be done when it comes to fermented novel foods," says Jenny Veide Vilg.

How does it affect food safety?

Fermentation has been used to preserve and process food for thousands of years. When fermentative bacteria are allowed to grow in food, they produce acids that lower the pH and create an environment that inhibits harmful bacteria. This in itself contributes to food safety. Some lactic acid bacteria also produce bacteriocins, which directly inhibit the growth of pathogenic micro-organisms.

Fermentation for novel food development also takes place in closed and controlled environments.

If a new ingredient is produced using genetically modified micro-organisms - as is often the case with precision fermentation - the product is subject to rigorous testing before it can be approved for food use in the EU. In many cases, the micro-organisms are also removed before the product reaches the consumer - particularly in the industrial production of milk protein, for example.

Jenny Veide Vilg

Enhetschef
+46 10 516 60 14 Read more about Jenny
Profile image

Contact Jenny

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Food Sekundär områdes navigation:
Circular transition
Biotechnology
Chemistry

LIGNOFUN

LIGNOFUN
LIGNOFUN

The pulp and paper industry in Europe produces 17 million tonnes of lignin every year. However, only two per cent is used for purposes other than energy production. The EU project LIGNOFUN aims to address this issue by developing bio-based products from lignin, thereby promoting a more sustainable and circular economy.

Koordinator
Active
Bioeconomy
Region Västernorrland
2029-05-31
Division: Division Bioeconomy

LIGNOFUN brings together 18 partners from across Europe – including leading research institutes, small and medium-sized enterprises, and major industrial players – to transform kraft lignin and black liquor, two abundant by-products of the pulp and paper industry, into high-performance, sustainable functional products.

The project aims to convert these underutilised streams into valuable aromatic compounds that are currently sourced from fossil-based materials by leveraging two cutting-edge lignin depolymerisation technologies. These bio-based ingredients will serve as essential building blocks for various applications, including foams, coatings, adhesives, wood panels, composites, personal care products, rubber antioxidants and nylon.

The project aims to demonstrate that not only can lignin-based materials match, but even outperform, fossil-based alternatives, while being better for the environment and reducing our dependence on finite resources. However, it’s not just about technology. LIGNOFUN also considers economic viability, societal benefits and regulatory aspects to ensure that the solutions are sustainable, safe and ready for large-scale deployment.

From side streams to value – LIGNOFUN’s mission for a greener industry

LIGNOFUN aims to utilise kraft lignin and black liquor, two underutilised by-products of the pulp and paper industry that are currently mostly burned for energy. By converting these by-products into sustainable, high-performance materials, we can replace substances derived from fossil fuels and contribute to a more circular, bio-based economy in Europe.

To achieve this, the project has three clear objectives combining innovation, sustainability and industrial benefit throughout the entire lignin valorisation process:

  1. Scalable Lignin Utilisation: Develop smart and cost-effective methods to extract and refine lignin into pure, aromatic building blocks.
  2. New bio-based products: Create and test prototypes of products such as foams, adhesives, coatings, composites, nylon, wood panels and cosmetics, and prove that they perform at least as well as today's fossil-based alternatives.
  3. Sustainability all the way: Evaluate the environmental, economic, and social impacts of lignin-based products, to ensure they are both competitive and fit for a future free from fossil dependency.

RISE’s role and mission

As coordinator of the LIGNOFUN project, RISE plays a central role in achieving the project's ambition of transforming kraft lignin and black liquor into sustainable, high-value functional products. With a mission to promote industrial innovation and the bioeconomy, RISE is responsible for the project's strategic and technical leadership, ensuring scientific excellence, effective collaboration and alignment with the EU’s climate and circularity goals.

RISE contributes a wide range of expertise and is responsible for several key areas within the project

  1. Project management: RISE oversees the project as a whole, coordinating collaboration between partners, managing dialogue with the EU and ensuring smooth day-to-day operations.
  2. Smart Data Management: RISE is developing a data management strategy to ensure that knowledge is shared securely and openly in line with FAIR principles.
  3. Lignin processing: A crucial task is refining lignin-based compounds to prepare them for use in subsequent processes. RISE purifies lignin-derived monoaromatics (LDMAs) by removing acids and salts to prepare them for microbial conversion in subsequent processes.
  4. Microorganism and Fermentation Development: RISE develops and optimizes bacterial strains that convert lignin compounds into valuable building blocks – both in laboratory settings and at larger scales.
  5. Green Chemical Conversion: Once the microbial processes have finished, RISE converts one of the main intermediate chemicals (ccMA) into adipic acid, which is a bio-based ingredient used in advanced plastics.
  6. Economics and sustainability: RISE evaluates the economic viability and societal relevance of the developed value chains through techno-economic analysis (TEA) and social sustainability and business development (SSBD).

The RISE research environments make all this possible. Within Bioeconomy Arena in Örnsköldsvik, for example, RISE provides advanced infrastructure for fermentation and microbial development, as well as reactors designed with industrial safety in mind. In Södertälje, RISE contributes expertise in chemical catalysis. Together, these environments form a robust foundation for scientific advancement and sustainable innovation throughout the LIGNOFUN project.

Vaskar Mukherjee

Principal Scientist
+46 10 516 67 61 Read more about Vaskar
Profile image

Contact Vaskar

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

Andreas S Johansson

Senior Forskare
+46 10 516 66 39 Read more about Andreas S
Profile image

Contact Andreas S

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
7. Affordable and clean energy
8. Decent work and economic growth
9. Industry, innovation and infrastructure
12. Responsible consumption and production
13. Climate action
17. Partnerships for the goals
Project end date: Fossil-free fuels Sekundär områdes navigation:
Circular transition
Biotechnology
Pulp and paper
Biobased materials
Chemical products and processes

Future Policy for the Future of Precision Medicine

FPFP

How can policy and regulation keep pace with the rapid advancement of medical technology? The project Future Policy for the Future of Precision Medicine explores how governance can enable innovative, safe and personalized healthcare.

Coordinator
Active
Life Science
Not applicable
One year
Approx. 1,2 MSEK
Division: Division Digital Systems and Societal Transformation

What regulations and policy tools are needed to bring tomorrow’s medical breakthroughs into today’s healthcare systems? That is the guiding question behind a new research initiative that puts governance and policy development – not technology itself – at the center. Focusing on precision medicine for inflammatory bowel disease (IBD), the project investigates how legal frameworks can enable the safe and effective use of cutting-edge technologies such as synthetic biology, multi-omics, and AI.

Through policy labs, testbeds, and an iterative process, the project develops new models for regulation and governance – always with real-world healthcare conditions and patient benefit in focus. The technological potential is vast: tailor-made biomolecules, genetically engineered cells, and predictive AI models may revolutionize how chronic diseases are treated. But innovation depends on regulatory readiness.

Led by RISE in collaboration with Region Skåne Innovation, Örebro University, and Pfizer AB, the project addresses legal and policy challenges that currently hinder progress. The outcome will provide concrete guidance for decision-makers and healthcare providers seeking to embrace innovation without compromising safety, integrity or quality of care.

Åse Lundh Gravenius

Senior forskare/Rättslig expert
+46 10 228 41 56 Read more about Åse
Profile image

Contact Åse

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
3. Good health and well-being
9. Industry, innovation and infrastructure
16. Peace, justice and strong institutions
Project end date: Drug development Sekundär områdes navigation:
Innovation management
Artificial intelligence
Data Science
Biotechnology

Formulation of RNA-adjuvans and mRNA-vaccines

Formulation of RNA-adjuvans & vaccines
Laboratory technician pipetting samples

Nanoparticle platforms for the delivery of RNA adjuvant and mRNA vaccines offer huge potential for innovation in vaccine technology and drug delivery. One of the benefits is the ability of nanoparticles to protect fragile RNA molecules from degradation by nucleases in the body, increasing the stability and longevity of the treatment.

Coordinator
Completed
Life Science
Region Stockholm
1 year
2 168 000 kr
Division: Division Life Science

The versatility of nanoparticles enables co-delivery of RNA adjuvant and mRNA vaccines within the same formulation platform. This creates a synergistic effect where the adjuvant enhances the ability of the vaccine to stimulate a robust and durable immune response. 

The project aims to strengthen the collaboration between RISE, PAI Life Sciences and HDT Bio on these formulations, to jointly seek long-term funding for the development of RNA delivery systems. 

The long-term goal is the development of next-generation carrier particles and adjuvant and RNA formulations for more effective vaccines. In the project we successfully developed and analyzed three innovative nanoparticle systems for RNA adjuvants and mRNA vaccines. Results demonstrated that mRNA binding and release can be controlled in these fundamentally different particular systems.

The ultimate goal is safer vaccines for a wide range of patients, including those with underlying health conditions that make them more vulnerable to side effects. 

Lina Nyström

Forskare
+46 10 516 65 33 Read more about Lina
Profile image

Contact Lina

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

Karin Persson

Teknisk Doktor
+46 10 516 60 72 Read more about Karin
Profile image

Contact Karin

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
3. Good health and well-being
Project end date: Offer-pages: Drug development - from idea to patient Drug development Sekundär områdes navigation:
Biotechnology
Composites
Chemical products and processes

Brewer's spent grain as food ingredient

Brewed & Renewed
Brewer's spent grain as food ingredient - photo credit to Carlsberg Sverige

Brewers’ spent grain (BSG) is a by-product that is formed in significant quantities during beer production. Currently, BSG is mainly used for animal feed and production of biogas. However, the high nutritional value of BSG means that it has great potential to be valorised into an innovative, healthy and environmentally sustainable food ingredient.

Projektledare
Active
Food
Not applicable
2 år
4000000 SEK
Division: Division Bioeconomy

Purpose and goals

This project aims at developing and optimising methods that contribute to an increased usage of BSG as a food ingredient. Specific goals include to:

  • develop a process for handling BSG in the entire chain from brewery to final product
  • improve the performance of BSG as food ingredient by optimisation of the processing (milling, fermentation, enzyme treatment)
  • establish the correlation between processing and the overall quality of the final products
  • produce in pilot-scale, and evaluate, one bread and one breakfast cereal, containing at least 30 % BSG

Challenges

There are several challenges that need to be resolved since there are a few factors that limit the use of BSG in the food industry. The high moisture content (70–80%) presents problems with microbial growth. In addition, the high fiber content can have a detrimental effect on sensory and rheological properties.

Solution

BSG requires pre-treatment to make it suitable for use in food products. Several processes can be applied and this work includes three of these, i.e. milling, fermentation and enzymatic processing. They are used both as stand-alone methods and in combination. These processes have different effects on the properties of BSG, especially regarding taste, texture and nutritional quality. 

Effect

This project aims at developing and optimising methods that contribute to an increased usage of BSG as a food ingredient generating nutritional and economic benefits, thereby contributing to the circular economy of this readily available side-stream.

Tim Nielsen

Forskare
Read more about Tim

Contact Tim

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Axfood Axfoundation Bageri Gruppen Carlsberg Elajo Fazer
Project end date: Food Sekundär områdes navigation:
Circular transition
Biotechnology
Chemical products and processes

Development of bio-based, sustainable MedTech disposable product

A bio-based MedTech disposable product
Samples of cellulose

The project explored the potential to develop a bio-based disposable medical device with low environmental impact. It involved identifying more sustainable materials for products intended for short-term use inside the body.

Coordinator
Completed
Medical devices
Västra Götaland Region
1 year
1 MSEK
Division: Division Materials and Industry

This feasibility study successfully showed that the concept is highly promising. A bio-based disposable product can significantly reduce environmental impact. The project established a strong interdisciplinary network and emphasized the importance of life cycle assessments in material and supplier choices. Prototypes were developed, regulations mapped, and a foundation laid for future innovation.

Challenges remain, but the possibility of using bio-based materials for invasive medical devices is groundbreaking. At RISE, we have extensive expertise and testing resources across key areas to support the transition to bio-based materials in disposable products—including LCA, biocompatibility evaluation, regulatory knowledge, and recycling potential assessment.

Karin Agrenius

Enhetschef
+46 10 516 59 42 Read more about Karin

Contact Karin

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

Henrik Bäckdahl

Forskare
+46 70 329 54 48 Read more about Henrik

Contact Henrik

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
3. Good health and well-being
Project end date: Offer-pages: Post-market support for medical devices Medtech Sekundär områdes navigation:
Biobased materials
Circular transition
Biotechnology

Multi-omics analysis

Multi-omics analysis
TapeStation chip for genomic DNA analysis

Recent developments in omic technologies are revolutionising the life sciences by opening up an unprecedented range of applications and opportunities. They allow us to tackle complex problems that could not be solved by previous approaches. Furthermore, the power of omic approaches increases exponentially when effectively integrated and combined.

At RISE, we harness the full potential of omic analysis to drive breakthrough research and innovation. We offer expertise and support in a range of high-throughput omic techniques and data analysis approaches. This includes:

  • Genomics and metagenomics: sequencing (next-generation sequencing, long-read sequencing) and analysing the entire set of DNA of an organism or microbial community (shotgun).
  • Epigenomics: determining and analysing epigenetic modifications across an entire genome (e.g., DNA methylation), which alter gene expression without changing the DNA sequence.
  • Transcriptomics: sequencing the complete set of RNA transcripts of an organism to elucidate gene expression patterns and changes through differential gene expression analysis.
  • Metatranscriptomics: sequencing and studying the RNA transcripts across an entire microbial community to gain insights into microbial functions and interactions.
  • Proteomics and metaproteomics: LC-MS/MS-based identification and analysis (qualitative and quantitative) of thousands of proteins of an organism or microbial community.
  • Glycomics: determining and analysing the whole set of glycans (glycome) of an organism.
  • Lipidomics: large scale analysis of the set of cellular lipids of an organism.
  • Metabolomics: profiling the set of metabolites and low-molecular weight molecules of an organism.
  • Phenomics: high-throughput assessment of phenotypic traits.
  • Integrative omics: combining data from multiple omic layers to provide a comprehensive understanding of biological systems and identify complex interactions.
  • Bioinformatics and statistics: utilising computational and statistical tools and methods for data integration, analysis and interpretation.
  • Artificial Intelligence: leveraging machine learning and AI to uncover patterns and predictions from vast datasets.

Our breadth of expertise and multidisciplinary nature provides end-to-end integrative and tailored solutions (from study design to data generation, analysis and interpretation). This enables us to generate and analyse complex datasets and gain meaningful insights into complex biological systems, driving scientific discovery and translational research. Through collaborations with academia, industry and healthcare, we strive to push the boundaries of what is possible in the life sciences.

Francisco Salva Serra

Forskare
+46 73 023 87 91 Read more about Francisco
Profile image

Contact Francisco

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

Nidal Ghosheh

Forskare
+46 10 516 56 79 Read more about Nidal

Contact Nidal

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Division: Division Materials and Industry Biotechnology

Creating new foods that consumers want

Woman is holding vegetarian burger

Innovative foods can make a difference to both the climate and health - but only if they are actually chosen and eaten. In a facility where new ingredients are processed into products such as sausages, mince and burgers, researchers are using advanced analytical methods and a taste-testing panel to pave the way for success at consumer level.

There are several parameters that consumers consider when filling their shopping baskets. Price is one of them, of course. For others, it is more important that the goods come from Sweden. Some look for food with a sustainability label, while others look for keyholes. However, certain parameters are always in the picture - taste and texture.

"For people to make a lifestyle change, it has to taste good, that's how we are. Many new food products are difficult to establish. People may try the product once, but if the taste is not good enough, there is a high risk that they will not buy it again," says Lina Svanberg, Head of Unit at RISE.

Today, there are many techniques for developing new foods. These include growing proteins from fungi and yeast in a controlled environment, such as at RISE's food-grade biotechnology infrastructure in Örnsköldsvik. Or developing plant-based foods that can supplement or replace animal products. The big challenge is to produce food that consumers actually choose, not just once, but on a regular basis. Product design plays an important role in this.

The answer lies in the detail

At RISE's food-approved facility in Gothenburg, nearly 30 researchers and engineers work on food design. The focus is on taste, texture and nutritional content. Much of the work revolves around understanding how to extract functional ingredients from a particular raw material and what type of food that ingredient is best suited to.

"We help companies to develop products that are not yet on the market, but also to optimise and improve the quality of existing ranges. In addition to being able to extract ingredients on a kilo scale and create products, for example through extrusion, baking and emulsification, we have very advanced analytical equipment," says Lina Svanberg, and continues:

"These include microscopy, which allows us to study what is happening in the product in great detail, often combined with measurements of texture and flow properties, as well as aroma analysis, which can detect bee flavours, for example. This helps the customer to answer questions such as why a product does not taste good or loses its consistency during storage."

Taste panel tests new foods

To further optimise the quality of the product, it is important to be able to taste it, says Lina Svanberg.

"There is no analytical instrument that can replace the human sense of taste. That's why it's an advantage that we can produce different products under food-grade conditions so that samples can actually be tasted," she says.

At the food facility, a trained sensory panel of 16 people with a keen sense of taste and the ability to describe taste and texture in a way that can be further used in product development.

Consumer testing is also used to better understand consumers' thoughts and perceptions of a product and how individual differences affect the taste experience. To get the right taste, texture and appearance of a product, it is important to understand what the consumer expects and wants from the product early in the product development process.

There is no analytical instrument that can replace the human sense of taste. That's why it's a strength that we can produce different products under food grade conditions so that samples can actually be tasted.

Hybrids are coming back

Looking to the future in the field of novel foods, Lina Svanberg points out that there is an increasing demand for the development of hybrid products (products in which parts of the animal raw material are replaced by, for example, a plant-based ingredient).

"Perhaps this is because it is difficult to make a completely plant- or fungus-based alternative that has a big impact. You want to do something because it's better than doing nothing, and hybrid products can be a step in that direction," she says.

RISE's product design team can also help develop and refine these types of novel foods. How do the different ingredients interact with each other, what effect does the manufacturing process have and how does it affect the taste and texture of the final product?

"It's a really exciting area to work in, and I can see how we can help our customers throughout the whole process of developing a product," says Lina Svanberg.

New sources of protein

Novel or alternative protein sources are foods and ingredients that can supplement or replace animal protein.

Plant-based proteins: for example, pea protein, soya protein and oats. 

Single cell protein: Microorganisms, such as filamentous fungi, are grown on industrial waste streams in closed bioreactor systems.

Aquatic protein: For example, algae and mussels.

Cell-cultured meat: meat that is produced from animal cells without the need for the slaughter of animals.

Lina Svanberg

Enhetschef
+46 10 516 66 79 Read more about Lina
Profile image

Contact Lina

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Food Sekundär områdes navigation:
Design
Biotechnology
Chemical and biological analysis

Enhancing viral detection and surface cleaning with bacteriphage model

Viral detection and surface cleaning

The project develops new methods to enhance virus detection and surface cleaning efficiency through innovative models and molecular techniques. The results contribute to improved hygiene in societally critical environments such as healthcare, food production, and public spaces, thereby reducing the spread of infections and safeguarding public healt

Coordinator
Active
Infection control
Västra Götaland Region
24 months
2 000 000
Division: Division Bioeconomy

Viral contamination of surfaces poses a significant public health risk, particularly in environments with high hygiene requirements such as healthcare settings, food production facilities, and public spaces. This project aims to develop advanced methods to enhance virus detection and cleaning efficiency. By utilizing innovative molecular techniques and safe bacteriophages as model organisms, the project will establish more reliable and scalable solutions for managing surface contamination.

The project's outcomes will enhance public health by contributing to safer cleaning methods and improved standards for hygiene assessment. By enabling faster and more specific detection of viruses and human fecal contamination, the project supports the development of more effective products and protocols, thereby reducing the spread of infections and protecting critical societal functions.

Innovation methods

The project introduces several novel approaches to enhance virus detection and cleaning efficiency:

  • A model system for testing wipes is being developed, which includes the introduction of various bacteriophages as model organisms to simulate viral behavior on surfaces. These bacteriophages are detected using both culture-based methods and molecular techniques, such as qPCR and the PMA-qPCR method. The PMA-qPCR method is specifically designed to differentiate between infectious and inactivated viral particles, providing a more comprehensive assessment of disinfection efficacy.

    CrAss-like phages are utilized as human-specific markers for fecal contamination, offering greater precision compared to traditional bacterial indicators.

These methods enable a realistic simulation of virus behavior on surfaces and a reliable evaluation of mechanical cleaning methods, contributing to the development of more effective hygiene solutions.

Objectives and impact

The project will deliver validated methods for measuring cleaning efficiency and virus detection, with a specific focus on surfaces such as wood, plastic, metal, and ceramics under various contamination conditions. The results are expected to improve cleaning products and protocols, reduce virus transmission, and enhance safety in public and professional environments.

3. Good health and well-being
6. Clean water and sanitation
Project end date: Infection control Sekundär områdes navigation:
Biotechnology
Food
Chemical and biological analysis